Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in Can J Neurol Sci Retrieve available abstracts of 29 articles: HTML format Text format

Single Articles

November 2011
1. MAMARABADI M , Razjouyan H, Mohammadi F, Moghaddasi M, et al
   Assessment of outcome predictors after first attack of optic neuritis.
   Can J Neurol Sci. 2011;38:887-95.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
2. BURTON JM , Alikhani K, Goyal M, Costello F, et al
   Complications in MS patients after CCSVI procedures abroad (Calgary, AB).
   Can J Neurol Sci. 2011;38:741-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. DEMERS M , Rouleau I, Scherzer P, Ouellet J, et al
   Impact of the cognitive status on the memory complaints in MS patients.
   Can J Neurol Sci. 2011;38:728-33.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. KREMENCHUTZKY M
   Safety, not only efficacy still to be proven for controversial new MS treatment.
   Can J Neurol Sci. 2011;38:667-8.
   PubMed     Text format     Related articles   
   
   
   
   May 2011
5. GIULIANI F , Catz I, Johnson E, Resch L, et al
   Loss of Purkinje Cells is Associated with Demyelination in Multiple Sclerosis.
   Can J Neurol Sci. 2011;38:529-31.
   PubMed     Text format     Related articles   
   
   
   
   
6. WONG J , Gomes T, Mamdani M, Manno M, et al
   Adherence to Multiple Sclerosis Disease-Modifying Therapies in Ontario is Low.
   Can J Neurol Sci. 2011;38:429-33.
   PubMed     Text format     Related articles   
   
   
   
   
7. KRYSKO KM , O'Connor PW
   The toronto observational study of natalizumab in multiple sclerosis.
   Can J Neurol Sci. 2011;38:422-8.
   PubMed     Text format     Related articles   
   
   
   
   March 2011
8. WALKER LA , Mendella PD, Stewart A, Freedman MS, et al
   Meaningful change in cognition in multiple sclerosis: method matters.
   Can J Neurol Sci. 2011;38:282-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2011
9. REYNOLDS LF , Short CA, Westwood DA, Cheung SS, et al
   Head pre-cooling improves symptoms of heat-sensitive multiple sclerosis patients.
   Can J Neurol Sci. 2011;38:106-11.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. WARREN S , Warren KG, Turpin KV
    Ultraviolet Radiation (UVR) and Risk of Developing Multiple Sclerosis (MS).
    Can J Neurol Sci. 2011;38:6-7.
    PubMed     Text format     Related articles   
    
    
    
    
11. ALIKHANI K , Lee DH, Kremenchutzky M
    Corpus callosum atrophy in a patient with neuromyelitis optica.
    Can J Neurol Sci. 2011;38:165-7.
    PubMed     Text format     Related articles   
    
    
    
    
12. SLOKA S , Silva C, Pryse-Phillips W, Patten S, et al
    A quantitative analysis of suspected environmental causes of MS.
    Can J Neurol Sci. 2011;38:98-105.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
13. WEIR B
    Multiple sclerosis - a vascular etiology?
    Can J Neurol Sci. 2010;37:745-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. OGER J , Alkhajawah M
    CCSVI: hope, hype or snake oil?
    Can J Neurol Sci. 2010;37:716.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
15. BROWN LN , Zhang Y, Mitchell JR, Zabad R, et al
    Corpus callosum volume and interhemispheric transfer in multiple sclerosis.
    Can J Neurol Sci. 2010;37:615-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. AKBAR N , Lobaugh NJ, O'Connor P, Moradzadeh L, et al
    Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients.
    Can J Neurol Sci. 2010;37:608-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. JOBIN C , Duquette P
    Brain, cognition and MRI in MS: an ongoing refinement process.
    Can J Neurol Sci. 2010;37:551-2.
    PubMed     Text format     Related articles   
    
    
    
    
18. STEINMAN L
    Inverse vaccination to silence immunity to myelin in multiple sclerosis.
    Can J Neurol Sci. 2010;37 Suppl 2:S49-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ANTEL J
    New directions in multiple sclerosis therapy: matching therapy with pathogenesis.
    Can J Neurol Sci. 2010;37 Suppl 2:S42-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. POWER C , Antony JM, Ellestad KK, Deslauriers A, et al
    The human microbiome in multiple sclerosis: pathogenic or protective constituents?
    Can J Neurol Sci. 2010;37 Suppl 2:S24-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. STYS PK
    Multiple sclerosis: autoimmune disease or autoimmune reaction?
    Can J Neurol Sci. 2010;37 Suppl 2:S16-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. MOORE GR
    Current concepts in the neuropathology and pathogenesis of multiple sclerosis.
    Can J Neurol Sci. 2010;37 Suppl 2:S5-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
23. HINNELL C , Almekhlafi M, Joseph JT, Bell R, et al
    Concurrence of high-grade brainstem glioma and multiple sclerosis.
    Can J Neurol Sci. 2010;37:512-4.
    PubMed     Text format     Related articles   
    
    
    
    
24. MORROW SA , Fraser JA, Nicolle D, Kremenchutzky M, et al
    Predicting conversion to MS--the role of a history suggestive of demyelination.
    Can J Neurol Sci. 2010;37:488-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
25. ROTSTEIN DL , Mamdani M, O'Connor PW
    Increasing use of disease modifying drugs for MS in Canada.
    Can J Neurol Sci. 2010;37:383-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. OGER J , AlKhawajah M
    Where are we going with drugs to treat MS? Will cost continue to increase?
    Can J Neurol Sci. 2010;37:305-8.
    PubMed     Text format     Related articles   
    
    
    
    March 2010
27. KAZIM SF , Islam M, Khan M, Hameed B, et al
    Risk of multiple sclerosis after idiopathic optic neuritis in a Pakistani population.
    Can J Neurol Sci. 2010;37:258-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
28. O'CONNOR PW
    Use of natalizumab in multiple sclerosis patients.
    Can J Neurol Sci. 2010;37:98-104.
    PubMed     Text format     Related articles   
    
    
    
    
29. HADER WJ
    Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan.
    Can J Neurol Sci. 2010;37:28-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: